nimustine has been researched along with Cancer of Gallbladder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitajima, Y; Koga, Y; Miyazaki, K; Miyoshi, A; Nakagawachi, T; Sato, K; Soejima, H | 1 |
1 other study(ies) available for nimustine and Cancer of Gallbladder
| Article | Year |
|---|---|
Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
Topics: Antineoplastic Agents; Base Sequence; Cell Line, Tumor; Cisplatin; DNA Primers; Gallbladder Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Molecular Sequence Data; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Plasmids; Promoter Regions, Genetic; Restriction Mapping; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion; Transcription, Genetic | 2005 |